
### [NCIT:C40389](http://purl.obolibrary.org/obo/NCIT_C40389)
**Label:** Breast Myoepithelial Tumor

**Subclasses:** [NCIT:C40388](http://purl.obolibrary.org/obo/NCIT_C40388) (Periductal Breast Myoepitheliosis), [NCIT:C40395](http://purl.obolibrary.org/obo/NCIT_C40395) (Malignant Breast Myoepithelioma), [NCIT:C40385](http://purl.obolibrary.org/obo/NCIT_C40385) (Breast Myoepitheliosis), [NCIT:C6899](http://purl.obolibrary.org/obo/NCIT_C6899) (Breast Adenomyoepithelioma), [NCIT:C5143](http://purl.obolibrary.org/obo/NCIT_C5143) (Malignant Breast Adenomyoepithelioma), [NCIT:C5144](http://purl.obolibrary.org/obo/NCIT_C5144) (Benign Breast Adenomyoepithelioma), 

**Class expressions from DL-Learner:**

- [NCIT:C36780](http://purl.obolibrary.org/obo/NCIT_C36780) (Malignant Myoepithelial Cell) 55.00%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) 55.00%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) 55.00%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) 55.00%
- Thing 52.57%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) 40.36%
- [NCIT:C36769](http://purl.obolibrary.org/obo/NCIT_C36769) (Abnormal Myoepithelial Cell) 40.36%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 40.36%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 40.36%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 40.36%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 40.36%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 40.36%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 40.36%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 40.36%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 40.36%


